Study from JAMA reveals that users of GLP-1 agonists, recent drugs for weight management, show a heightened risk of gastrointestinal complications like intestinal obstruction, gastroparesis, and pancreatitis. Though these effects are rare, those considering these drugs for weight loss should weigh the benefits against potential risks, especially if not using them for diabetes.
Cedars-Sinai researchers discover why some injured kidneys heal while others develop scarring
Cedars-Sinai investigators have discovered why some injured kidneys heal while others develop scarring that can lead to kidney failure.